Literature DB >> 7570012

Antisense has growing pains.

T Gura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570012     DOI: 10.1126/science.270.5236.575

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

1.  Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency.

Authors:  W M Flanagan; A Kothavale; R W Wagner
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

Review 2.  Growth factors in gliomas: antisense and dominant negative mutant strategies.

Authors:  J W Campbell; I F Pollack
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

3.  Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.

Authors:  U Koppelhus; V Zachar; P E Nielsen; X Liu; J Eugen-Olsen; P Ebbesen
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

4.  Effect of c-myc antisense oligodeoxynucleotides on hypoxia-induced proliferation of pulmonary vascular pericytes.

Authors:  L Wang; M Xiong; D Che; X Zheng
Journal:  J Tongji Med Univ       Date:  2000

Review 5.  Transgenic and transcriptional studies on neurosecretory cell gene expression.

Authors:  S J Waller; A Ratty; J P Burbach; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

6.  Introduction and History of the Chemistry of Nucleic Acids Therapeutics.

Authors:  Michael J Gait; Sudhir Agrawal
Journal:  Methods Mol Biol       Date:  2022

7.  Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.

Authors:  G Hartmann; A Krug; K Waller-Fontaine; S Endres
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

Review 8.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

9.  Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Authors:  D Byrne; C Daly; R Nicamhlaoibh; A Howlett; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

10.  SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression.

Authors:  C Allal; S Sixou; R Kravtzoff; N Soulet; G Soula; G Favre
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.